Here, we briefly describe pathogenetic, clinical, and prognostic characteristics of adult t(4;11)(q21;q23)/MLL-AF4 positive ALL and review the therapeutic approaches proposed for its treatment by most of the important cooperative groups worldwide. Here, KMT2A is linked to acute lymphoblastic leukemia.